首页 > 市场调查报告书 > 製药

医药品法规环境

市场调查报告书

商品编码

1593463

药物安全检测和药物安全软体市场规模、份额、成长分析、按功能、按部署模式、按最终用户、按地区 - 行业预测，2024-2031 年

Pharmacovigilance and Drug Safety Software Market Size, Share, Growth Analysis, By Functionality, By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月11日 | 出版商:

SkyQuest | 英文 207 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球药物安全检测和药物安全软体市场规模为1.823亿美元，在预测期内从2023年的1.9433亿美元增长到2031年的3.2404亿美元（预计从2024年起复合年增长率为10.5%）到2031 年）。

全球药物安全检测和药物安全软体市场由旨在加强药物不良反应(ADR) 和其他安全问题的追踪、分析和报告的专门程序组成，特别是在罗马尼亚，它对医疗保健提供者和监管机构变得越来越重要。这些软体工具可以有效收集、管理和分析各种药物安全资料，帮助製药公司和医疗保健专业人员监控药物有效性和副作用。识别潜在风险和新趋势，以促进及时干预和风险缓解策略。这些解决方案的主要使用者包括领先的药物安全检测提供者、业务流程外包 (BPO) 公司和合约委外研发机构(CRO)。随着市场的发展，它将受到多种动态的影响，例如ADR发生率的上升和组织间外包趋势的上升，预计这将推动采用率的提高。此外，FDA 和 EMEA 等监管机构正在推动更严格的药品安全标准，进一步刺激该行业的成长。因此，药物安全检测和药物安全软体市场前景光明，其特点是由于对安全药物治疗实践和有效管理药物相关风险的需求而显着扩张。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 阿拉伯联合大公国国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Oracle Corporation
Veeva Systems Inc.
AB-Cube
ArisGlobal

简介目录

Product Code: SQMIG35G2302

Global Pharmacovigilance and Drug Safety Software Market size was valued at USD 182.3 Million in 2022 poised to grow from USD 194.33 Million in 2023 to USD 324.04 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The global pharmacovigilance and drug safety software market, which consists of specialized programs aimed at enhancing the tracking, analysis, and reporting of Adverse Drug Reactions (ADRs) and other safety issues, is increasingly vital for healthcare providers and regulatory agencies, particularly in Romania. These software tools enable efficient collection, management, and analysis of extensive data concerning drug safety, assisting pharmaceutical companies and healthcare professionals in monitoring medication effectiveness and side effects. By identifying potential risks and emerging trends, they facilitate timely interventions and risk mitigation strategies. Primary users of these solutions include large pharmacovigilance providers, business process outsourcing (BPO) firms, and contract research organizations (CROs). As the market evolves, it is influenced by multiple dynamics, including the rising incidence of ADRs and the growing trend of outsourcing among organizations, which is expected to propel adoption rates. Moreover, increased regulatory scrutiny from agencies such as the FDA and EMEA demanding heightened safety standards in pharmaceuticals is further fueling growth in this sector. Consequently, the pharmacovigilance and drug safety software market is poised for a promising future, characterized by significant expansion driven by the necessity for safe medication practices and the effective management of drug-related risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacovigilance And Drug Safety Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance And Drug Safety Software Market Segmental Analysis

Global Pharmacovigilance and Drug Safety Software Market is segmented by Function, Deployment Mode, End User and region. Based on Function, the market is segmented into Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software Based on Deployment Mode, the market is segmented into On Premise and Cloud. Based on end user, the market is segmented into Pharma and Biotech Companies, Contract Research Organizations, Business Process Outsourcing and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pharmacovigilance And Drug Safety Software Market

The escalating demand for pharmacovigilance and drug safety software is primarily propelled by stringent global regulatory frameworks enforced by authorities such as the FDA and EMA. These regulations mandate rigorous adverse event reporting and continuous drug safety monitoring, compelling pharmaceutical companies to adopt reliable software solutions that streamline compliance processes. As the drug development landscape becomes increasingly complex, the need for scalable and effective pharmacovigilance systems intensifies, enabling firms to efficiently manage regulatory obligations, mitigate risks, and enhance patient safety. This growing emphasis on regulatory adherence not only drives innovations in software development but also positions pharmacovigilance solutions as indispensable assets in the pharmaceutical industry.

Restraints in the Global Pharmacovigilance And Drug Safety Software Market

The Global Pharmacovigilance and Drug Safety Software market faces significant restraints due to the complex integration of novel software with existing systems and workflows. This challenge often leads to disruptions in operations, as organizations grapple with data migration issues to ensure compatibility with older systems that may lack modern efficiencies. Additionally, the high costs associated with advanced solutions deter many companies from adopting these technologies, resulting in prolonged implementation timelines. Consequently, the reluctance to invest in and transition to more effective pharmacovigilance tools curtails market growth, as businesses weigh the operational hassles against the benefits of new solutions.

Market Trends of the Global Pharmacovigilance And Drug Safety Software Market

The global pharmacovigilance and drug safety software market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning technologies. These advancements facilitate superior data analytics, enabling more efficient automation of adverse event reporting and enhanced predictive capabilities. As a result, stakeholders can achieve improved accuracy and efficacy in drug safety management, leading to better compliance with regulatory standards. This trend reflects a broader shift towards digitization and automation within the healthcare sector, fostering a proactive approach to drug safety and risk management, ultimately ensuring the protection of public health and enhancing pharmaceutical innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Trade Analysis
Startup Analysis
Supply Chain Analysis
Pricing Analysis

Global Pharmacovigilance and Drug Safety Software Market Size by Function & CAGR (2024-2031)

Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Global Pharmacovigilance and Drug Safety Software Market Size by Deployment Mode & CAGR (2024-2031)

On Premise
On Cloud

Global Pharmacovigilance and Drug Safety Software Market Size by End User & CAGR (2024-2031)

Pharma and Biotech Companies
Contract Research Organizations
Business Process Outsourcing
Other

Global Pharmacovigilance and Drug Safety Software Market Size & CAGR (2024-2031)

North America, (Function, Deployment Mode, End User)
- US
- Canada
Europe, (Function, Deployment Mode, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Function, Deployment Mode, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Function, Deployment Mode, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Function, Deployment Mode, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veeva Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB-Cube
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArisGlobal
- Company Overview
- Business Segment Overview